Healthcare -
Biotechnology - NASDAQ - BM
$ 18.54
0.816 %
$ 1.34 B
Market Cap
-154.5
P/E
KNSA - OPERATING INCOME
Operating Income KNSA - Kiniksa Pharmaceuticals, Ltd.
-25.2 M
LAST VALUE
59.89%
2 YEAR CAGR
25.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR